Skip to main content

Table 2 Statistical analysis of treatment outcomes in 522 patients with DFIs

From: Prevalence of S. aureus and/or MRSA in hospitalized patients with diabetic foot and establishment of LAMP methods for rapid detection of the SCCmec gene

Type

Group

Cases

Osteomyelitis

Amputation/Disability

Length of hospital stay

Median

P25

P75

IQR

Range

145 cases of S. aureus infection

Only MSSA

53

11 (20.8%)

11 (20.8%)

11

8

15.5

7.5

5–37

Only MRSA

31

15 (48.4%)

14 (45.2%)

16

12

22

10

5–45

Multiple bacteria were co-isolated with MSSA

43

6 (14.0%)

6 (14.0%)

13

8

21

13

5–42

Multiple bacteria were co-isolated with MRSA

18

8 (44.4%)

6 (33.3%)

18.5

10

28.25

18.25

6–43

377 cases of other types of bacterial infection

only coagulase-negative Staphylococcus

53

3 (5.7%)

6 (11.3%)

12

9

17.5

8.5

3–46

Only Enterococcus

25

5 (20.0%)

5 (20.0%)

14

5

49

44

9–22.5

Only Streptococcus

19

4 (21.1%)

3 (15.8%)

12

8

20

12

3–29

Only Enterobacter

62

16 (25.8%)

16 (25.8%)

14

9

22

13

4–40

Only non-fermentative bacteria

19

3 (15.8%)

2 (10.5%)

18

11

28

17

4–63

Only Candida

15

2 (13.3%)

2 (13.3%)

11

8

21

13

6–67

Multiple bacteria without MSSA/MRSA

184

37 (22.1%)

38 (20.7%)

16

10.25

22.75

12.5

1–69

  1. Significant differences were observed in the rates of Osteomyelitis, Amputation, and hospitalization days among the infection groups (P < 0.05)
  2. Data is presented as n (%). The bolded characters represent information about patients who were infected with MRSA
  3. Abbreviations: DFIs Diabetic Foot Infections, MSSA Methicillin-Susceptible Staphylococcus Aureus, MRSA Methicillin-Resistant Staphylococcus Aureus, IQR (InterQuartile Range)